Advanced Cholangiocarcinoma Clinical Trials in Hangzhou, Zhejiang
3 recruitingHangzhou, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Advanced CholangiocarcinomaFGFR2 FusionsGene Rearrangement
Taiho Oncology, Inc.120 enrolled65 locationsNCT05727176
Recruiting
Phase 3
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
Advanced Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT05823311
Recruiting
Phase 2
Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
Advanced Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05532059